Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy

Russell Rosenberg, Michael J. Thorpy, Yves Dauvilliers, Paula K. Schweitzer, Gary Zammit, Mark Gotfried, Shay Bujanover, Brian Scheckner, Atul Malhotra

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy'. Together they form a unique fingerprint.

Medicine & Life Sciences